Vinpocetine Drug Interactions, Uses, Effectiveness, Safety & More
What is this page for?
First and foremost: how Vinpocetine interacts with medications. The heart of this page is the interaction list — every drug Vinpocetine is known to interact with, and how serious each one is.
But these pages have grown well beyond that into a full monograph — what Vinpocetine is, what people use it for and how strong the evidence is, its safety and side effects, and answers to the questions we’re asked most — written and reviewed by the clinical staff at HelloPharmacist. It’s educational information from our licensed clinical databases, not medical advice, and we don’t sell or endorse products. Our editorial policy
Check Vinpocetine against your medication
Add one medicationVinpocetine Drug Interactions: The Bottom Line
From the HelloPharmacist Editorial Team · Updated July 2026Based on the available evidence, the overall risk of a clinically significant Vinpocetine drug interaction appears low for most people, though anyone on a blood thinner deserves extra care. None of the listed interactions are rated major, and most rest on lab findings or small effects that have not been shown to cause meaningful problems in people.
The interactions that matter most involve anticoagulant and antiplatelet drugs. Human research shows vinpocetine can thin the blood in several ways, so adding it to a blood thinner could raise bleeding risk. Notably, warfarin has been studied directly with vinpocetine, and the changes seen were small; researchers felt this combination is unlikely to cause real problems for most patients. Still, because warfarin and similar medicines have a narrow safety margin, this pairing deserves attention.
The long list of interacting medications looks worse than it is. Most entries come from a single theoretical concern: lab research suggests vinpocetine might weakly slow an enzyme the body uses to clear certain medications, but this effect has never been reported in humans. In other words, many of these interactions are predicted rather than proven.
Based on HelloPharmacist’s Vinpocetine interaction data and reviewed under our editorial standards.
Drugs that interact with Vinpocetine
209 medications have a known interaction with Vinpocetine, graded by severity. Select any drug for the full evidence-based detail.
Don’t want to scroll the list? Just ask.
Tell us the medications you take and we’ll check each one against Vinpocetine using our pharmacist-reviewed interaction data.
AI summaries are generated from our Vinpocetine interaction data for education only — always confirm with your pharmacist. How we use AI
No drugs match “”.
What Severity, Likelihood & Evidence Mean
Severity — How Serious It Can Be
- Major. Clinically significant; generally best avoided, or used only under direct professional supervision.
- Moderate. May need monitoring, a dose adjustment, or separating the times you take each one.
- Minor. Generally not clinically significant, but still worth noting and mentioning to your pharmacist.
- No known interaction. Checked against our sources with nothing documented — not the same as proven safety.
Likelihood — How Well It’s Documented
- Likely. Well-controlled human studies have demonstrated the likely existence of this interaction
- Probable. Interaction has not been documented in well-controlled studies, however, the interaction has been demonstrated in some small human studies or in controlled animal studies in conjunction with multiple case reports.
- Possible. Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists
- Unlikely. Interaction has been demonstrated in animal or in lab research but has been shown not to occur in humans.
Where This Data Comes From
- Interaction records are evidence-graded and sourced from the Natural Medicines database (TRC Healthcare), the same reference used by pharmacists and hospitals.
- Each drug listed above links to the full report for that exact Vinpocetine combination — clinical detail, likelihood, evidence level, and citations.
- Content is reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.
The kinds of drugs Vinpocetine affects
Every type of medication (drug category) Vinpocetine is known to interact with. Open any category for the detail — or search your exact drug in the checker above.
Anticoagulant/Antiplatelet Drugs
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Clinical research shows that vinpocetine decreases red blood cell aggregation, as well as plasma and whole blood viscosity. This effect has been seen with intravenous vinpocetine 1 mg/kg and oral vinpocetine 30 mg daily. Vinpocetine also seems to have antiplatelet effects.
Cytochrome P450 2C9 (Cyp2C9) Substrates
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
In vitro research shows that vinpocetine weakly inhibits CYP2C9. However, this effect has not been reported in humans.
Warfarin (Coumadin)
Vinpocetine might modestly increase the risk of bleeding when taken with warfarin.
Clinical research shows that the combination of warfarin and vinpocetine leads to slight increases in prothrombin time and the area under the concentration curve for warfarin. However, these increases were small, and researchers suggest that this interaction is not likely to be clinically significant in most patients.
Vinpocetine: Uses, Safety & Side Effects
Vinpocetine is a lab-made compound based on a chemical from the periwinkle plant, and it is marketed mainly for memory and brain health. The evidence behind these uses is limited and not strong, and U.S. regulators have warned that it should be avoided by people who are pregnant or could become pregnant. Talk with your pharmacist or doctor before trying it.

- Family
- Apocynaceae
- Part used
- Synthetic compound derived from vincamine, an alkaloid found in lesser periwinkle (Vinca minor) leaves
- Common forms
- Capsules, tablets, powder
- Memory and cognitive support
- Brain blood flow
- Stroke recovery
- Age-related memory decline
- Tinnitus and hearing concerns
Popular and traditional uses — not proof it works. See “Uses & effectiveness” below for the evidence.
It is generally well tolerated short-term, but long-term safety and quality of supplements are not well established.
When used orally. In June 2019, the US Food and Drug Administration (FDA) issued a statement of warning that those who are pregnant or who could becom...
Read the full pregnancy detailInsufficient reliable information available; avoid using.
Read the full breastfeeding detailPregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center). Safety guidance is general; always confirm with your pharmacist or doctor for your situation.
Overview
Vinpocetine is a man-made (synthetic) compound. It is created from vincamine, a natural chemical called an alkaloid found in the leaves of the lesser periwinkle plant (Vinca minor), a low-growing plant native to parts of Europe.
In some countries vinpocetine is sold as a prescription medicine for brain and circulation problems. In the United States it is sold as a dietary supplement. People most often take it hoping to support memory, thinking, and blood flow to the brain.
How it works
Researchers believe vinpocetine may affect the brain in several ways. It is thought to widen blood vessels and improve blood flow, and it may help brain cells use oxygen and glucose. It may also block certain enzymes (such as a type called phosphodiesterase) and affect ion channels involved in nerve signaling.
It has also been studied for possible anti-inflammatory and antioxidant effects. Most of this information comes from laboratory and animal studies, so it is not clear how meaningful these effects are in people who take it as a supplement.
Does Vinpocetine work?
How to read these evidence grades
Natural Medicines’ 7-point scale. We show each rating’s label word-for-word.
Possibly Effective Dementia
Oral vinpocetine, taken for up to 1 year, might improve cognitive function to a small degree in patients with dementia.
Also studied for 11 conditions — evidence insufficient to rate
Insufficient Reliable Evidence To Rate Age-related cognitive decline
Although there has been interest in using oral vinpocetine for age-related cognitive decline, there is insufficient reliable information about the clinical effects of vinpocetine for this purpose.
Insufficient Reliable Evidence To Rate Age-related macular degeneration (AMD)
It is unclear if oral vinpocetine is beneficial in patients with AMD.
Insufficient Reliable Evidence To Rate Chronic fatigue syndrome (CFS)
Although there has been interest in using oral vinpocetine for CFS, there is insufficient reliable information about the clinical effects of vinpocetine for this purpose.
Insufficient Reliable Evidence To Rate Epilepsy
Although there has been interest in using oral and intravenous vinpocetine for epilepsy, there is insufficient reliable information about the clinical effects of vinpocetine for this purpose.
Insufficient Reliable Evidence To Rate Hearing loss
It is unclear if oral or intravenous vinpocetine is beneficial in patients with hearing loss.
Insufficient Reliable Evidence To Rate Memory
Small clinical studies suggest that oral vinpocetine might slightly improve memory in healthy individuals.
Insufficient Reliable Evidence To Rate Menopausal symptoms
Although there has been interest in using oral vinpocetine for menopausal symptoms, there is insufficient reliable information about the clinical effects of vinpocetine for this purpose.
Insufficient Reliable Evidence To Rate Motion sickness
Although there has been interest in using oral vinpocetine for motion sickness, there is insufficient reliable information about the clinical effects of vinpocetine for this purpose.
Insufficient Reliable Evidence To Rate Stroke
Research on the use of intravenous vinpocetine to improve outcomes in patients recovering from ischemic stroke is mixed. It is unclear if oral vinpocetine is beneficial in these patients.
Insufficient Reliable Evidence To Rate Tinnitus
It is unclear if oral or intravenous vinpocetine is beneficial in patients with tinnitus.
Insufficient Reliable Evidence To Rate Urinary incontinence
It is unclear if oral vinpocetine is beneficial in patients with urinary incontinence.
Source & disclaimer. Effectiveness ratings and evidence summaries are provided by Natural Medicines (Therapeutic Research Center) and shown as licensed. Where Natural Medicines hasn’t rated a use, HelloPharmacist’s pharmacists may add their own reviewed rating and evidence (each such entry is labeled). This is educational information, not medical advice — talk with your pharmacist or doctor before starting, stopping, or changing a supplement.
Safety & precautions
Vinpocetine appears to be reasonably well tolerated when used short-term, but its long-term safety has not been well studied. Because it is sold as a supplement in the U.S., product quality and the actual amount in each capsule can vary between brands.
Pregnancy: The U.S. Food and Drug Administration (FDA) has specifically warned that vinpocetine may harm a developing baby and that people who are pregnant or could become pregnant should not take it. Avoid it during pregnancy.
Breastfeeding: There is not enough safety information, so it is best to avoid vinpocetine while breastfeeding.
People with bleeding disorders, those scheduled for surgery, people with low blood pressure, and anyone with a weakened immune system should be cautious because of possible effects on blood and immune cells. Always check with a pharmacist or doctor before starting it.
Side effects
Reported side effects are usually mild and may include stomach upset, nausea, headache, dizziness, drowsiness, flushing, and sleep changes. Some people notice a temporary drop in blood pressure.
Less common concerns include effects on the immune system and possible changes in how the blood clots. If you have any unusual or severe symptoms, stop taking it and contact a healthcare provider.
Vinpocetine: Reported Adverse Effects
Documented safety reports on Vinpocetine from the evidence-graded Natural Medicines (TRC Healthcare) database, shown word-for-word from the licensed record.
Orally and intravenously, vinpocetine seems to be well tolerated.
Most Common Adverse Effects:
Orally: Anxiety, dizziness, headache, flushing, gastric discomfort, sleep disturbances, and urticaria.
Serious Adverse Effects (Rare):
Orally: Agranulocytosis, arrhythmias, and seizures.
Intravenously: Arrhythmias.
Anxiety Neurologic/CNS
Orally, anxiety, drowsiness, headache, sleep disturbance, nervousness, excitation, hyperirritability, epileptiform convulsion, and vertigo have been reported with vinpocetine. Intravenously, dizziness has been reported with vinpocetine.
- Hindmarch I, Fuchs HH, Erzigkeit H. Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes. Int Clin Psychopharmacol 1991;6:31-43.
- Wollschlaeger B. Efficacy of vinpocetine in the management of cognitive impairment and memory loss. JANA 2001;4:25-30.
- Fischhof, P. K., Moslinger-Gehmayr, R., Herrmann, W. M., Friedmann, A., and Russmann, D. L. Therapeutic efficacy of vincamine in dementia. Neuropsychobiology 1996;34(1):29-35.
- Kovacs, L. Cavinton in the treatment of acute stroke. Ther Hung. 1985;33(1):50-57.
- Ebi, O. Open-labeled phase III clinical trials with vinpocetine in Japan. Ther.Hung. 1985;33(1):41-49.
- Fenzl, E., Apecechea, M., Schaltenbr, R., and Fridel, R. Long term study concerning tolerance and efficacy of vinpocetine in elderly patients suffering from a mild to moderate organic psychosyndrome. Senile dementia: early detection 1986;580-585.
- Peruzza, M. and DeJacobis, M. A double-blind placebo controlled evaluation of the efficacy and safety of vinpocetine in the treatment of patients with chronic vascular or degenerative senile cerebral dysfunction. ADV THER 1986;3(4):201-209.
- Blaha, L., Erzigkeit, H. L., Adamczyk, L. A., Freytag, L. S., and Schaltenbrand, R. Clinical evidence of the effectiveness of vinpocetine in the treatment of organic psychosyndrome. Human Psychopharmacology: Clinical & Experimental 1989;4(2):103-111.
- Vinpocetine in Dietary Supplements. FDA Food/Dietary Supplements/Products & Ingredients. Available at: http://www.fda.gov/Food/DietarySupplements/ProductsIngredients/ucm518478.htm. Accessed 6 September 2016.
- Gutiérrez-Farfán I, Reyes-Legorreta C, Solís-Olguín M, Alatorre-Miguel E, Verduzco-Mendoza A, Durand-Rivera A. Evaluation of vinpocetine as a therapy in patients with sensorineural hearing loss: a phase II, open-label, single-center study. J Pharmacol Sci
- Zhang W, Huang Y, Li Y, et al. Efficacy and safety of vinpocetine as part of treatment for acute cerebral infarction: A randomized, open-label, controlled, multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) trial. Clin Drug Investig 2016;
Arrhythmia Cardiovascular
Orally, tachycardia, multifocal extra systoles, transient hypotension and hypertension, and palpitations have been reported with vinpocetine in clinical trials. One case of severe hypotension has been reported with oral vinpocetine. Vinpocetine has also been reported to cause atrial fibrillation and ventricular arrhythmias, with the highest incidence occurring after intravenous or intramuscular administration.
- Balestreri R, Fontana L, Astengo F. A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction. J Am Geriatr Soc 1987;35:425-30.
- Kovacs, L. Cavinton in the treatment of acute stroke. Ther Hung. 1985;33(1):50-57.
- Peruzza, M. and DeJacobis, M. A double-blind placebo controlled evaluation of the efficacy and safety of vinpocetine in the treatment of patients with chronic vascular or degenerative senile cerebral dysfunction. ADV THER 1986;3(4):201-209.
- Vinpocetine in Dietary Supplements. FDA Food/Dietary Supplements/Products & Ingredients. Available at: http://www.fda.gov/Food/DietarySupplements/ProductsIngredients/ucm518478.htm. Accessed 6 September 2016.
- Gutiérrez-Farfán I, Reyes-Legorreta C, Solís-Olguín M, Alatorre-Miguel E, Verduzco-Mendoza A, Durand-Rivera A. Evaluation of vinpocetine as a therapy in patients with sensorineural hearing loss: a phase II, open-label, single-center study. J Pharmacol Sci
- Dany, F., Merle, L., Goudoud, J. C., Liozon, F., Blanc, P., Bouvot, J. C., Nicot, G., and Dangoumau, J. [Cardiac toxicity of vincamine: a seven cases report of ventricular arrhythmias by parenteral administration of vincamine (author's transl)]. Therapie
- Dekoninck, W. J., Jocquet, P., Jacquy, J., and Henriet, M. Comparative study of the clinical effects of vincamine + glycerol versus glycerol + placebo in the acute phase of stroke. Arzneimittelforschung. 1978;28(9):1654-1657.
- Richichi, I., Valsecchi, O., Falcone, C., Sofi, A., and Zanini, L. [A case of "torsade de pointe" during vincamine therapy]. Minerva Cardioangiol. 1978;26(3):197-200.
Constipation Gastrointestinal
Orally, gastric discomfort, upper abdominal pain, nausea, diarrhea, constipation, vomiting, heartburn, difficulty swallowing, and dry mouth have been reported with vinpocetine. Intravenously, diarrhea has been reported with vinpocetine.
Dermatitis Dermatologic
Orally, vinpocetine has been reported to cause flushing, skin rash, and urticaria. Intravenously, vinpocetine has been associated with one report of allergic dermatitis.
- Kovacs, L. Cavinton in the treatment of acute stroke. Ther Hung. 1985;33(1):50-57.
- Ebi, O. Open-labeled phase III clinical trials with vinpocetine in Japan. Ther.Hung. 1985;33(1):41-49.
- Manconi, E., Binaghi, F., and Pitzus, F. A double-blind clinical trial of vinpocetine in the treatment of cerebral insufficiency of vascular and degenerative origin. CURR THER RES, CLIN EXP 1986;40(4):702-709.
- Gutiérrez-Farfán I, Reyes-Legorreta C, Solís-Olguín M, Alatorre-Miguel E, Verduzco-Mendoza A, Durand-Rivera A. Evaluation of vinpocetine as a therapy in patients with sensorineural hearing loss: a phase II, open-label, single-center study. J Pharmacol Sci
- Zhang W, Huang Y, Li Y, et al. Efficacy and safety of vinpocetine as part of treatment for acute cerebral infarction: A randomized, open-label, controlled, multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) trial. Clin Drug Investig 2016;
Myasthenia gravis Ocular/Otic
Orally, vinpocetine has been associated with one case of eyelid edema. Also, one case reports ecchymoma of the eyelid in a 60-year-old male 12 hours after a botulinum toxin injection. The patient had been taking vinpocetine 30 mg daily and aspirin 100 mg daily.
- Gutiérrez-Farfán I, Reyes-Legorreta C, Solís-Olguín M, Alatorre-Miguel E, Verduzco-Mendoza A, Durand-Rivera A. Evaluation of vinpocetine as a therapy in patients with sensorineural hearing loss: a phase II, open-label, single-center study. J Pharmacol Sci
- Hu X, Guo K, Li J, et al. Postoperative ecchymoma of eyelid after botulinum toxin injection for hemifacial spasm: a case report. Front Neurol 2023;14:1171303.
Myasthenia gravis Hematologic
Orally, vinpocetine has been associated with one case report of agranulocytosis and one case report of ecchymoma of the eyelid in a 60-year-old male 12 hours after a botulinum toxin injection. The patient had been taking vinpocetine 30 mg daily and aspirin 100 mg daily.
- Shimizu, Y., Saitoh, K., Nakayama, M., Suto, K., Daikohara, R., and Nemoto, T. Agranulocytosis induced by vinpocetine. Medicine On-line 2011;
- Hu X, Guo K, Li J, et al. Postoperative ecchymoma of eyelid after botulinum toxin injection for hemifacial spasm: a case report. Front Neurol 2023;14:1171303.
Adverse-effects data: Natural Medicines, Therapeutic Research Center
Dosing
There is no officially established or standardized dose for vinpocetine as a supplement, and products vary widely. Because of this, the safest approach is to follow the directions on the product label and not exceed them.
Before starting vinpocetine, talk with your pharmacist or doctor, especially if you take other medicines or have any health conditions. They can help you decide whether it is appropriate and review the product for quality and safety.
Vinpocetine & Pregnancy
Vinpocetine & Breastfeeding
© 2026 Therapeutic Research Center
Pregnancy & lactation ratings: Natural Medicines, Therapeutic Research Center
References & further reading
The 27 references that drive our Vinpocetine monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.
- Hindmarch I, Fuchs HH, Erzigkeit H. Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes. Int Clin Psychopharmacol 1991;6:31-43. PubMed
- Balestreri R, Fontana L, Astengo F. A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction. J Am Geriatr Soc 1987;35:425-30. PubMed
- Akopov SE, Gabrielian ES. Effects of aspirin, dipyridamole, nifedipine and cavinton which act on platelet aggregation induced by different aggregating agents alone and in combination. Eur J Clin Pharmacol 1992;42:257-9. PubMed
- Kidd PM. A review of nutrients and botanicals in the integrative management of cognitive dysfunction. Altern Med Rev 1999;4:144-61..
- Wollschlaeger B. Efficacy of vinpocetine in the management of cognitive impairment and memory loss. JANA 2001;4:25-30.
- Hitzenberger G, Sommer W, Grandt R. Influence of vinpocetine on warfarin-induced inhibition of coagulation. Int J Clin Pharmacol Ther Toxicol 1990;28:323-8..
- Dekoninck, W. J., Jocquet, P., Jacquy, J., and Henriet, M. Comparative study of the clinical effects of vincamine + glycerol versus glycerol + placebo in the acute phase of stroke. Arzneimittelforschung. 1978;28(9):1654-1657.
- Fischhof, P. K., Moslinger-Gehmayr, R., Herrmann, W. M., Friedmann, A., and Russmann, D. L. Therapeutic efficacy of vincamine in dementia. Neuropsychobiology 1996;34(1):29-35. PubMed
- Feher, G., Koltai, K., Kesmarky, G., Horvath, B., Toth, K., Komoly, S., and Szapary, L. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases. Phytomedicine. 2009;16(2-3):111-117. PubMed
- Kuzuya, F. Effects of vinpocetine on platelet aggregability and erythrocyte deformability. Ther Hung. 1985;33(1):22-34.
- Kovacs, L. Cavinton in the treatment of acute stroke. Ther Hung. 1985;33(1):50-57.
- Osawa, M. and Maruyama, S. Effects of TCV-3B (vinpocetine) on blood viscosity in ischemic cerebrovascular diseases. Ther.Hung. 1985;33(1):7-12.
- Ebi, O. Open-labeled phase III clinical trials with vinpocetine in Japan. Ther.Hung. 1985;33(1):41-49.
- Richichi, I., Valsecchi, O., Falcone, C., Sofi, A., and Zanini, L. [A case of "torsade de pointe" during vincamine therapy]. Minerva Cardioangiol. 1978;26(3):197-200.
- Dany, F., Merle, L., Goudoud, J. C., Liozon, F., Blanc, P., Bouvot, J. C., Nicot, G., and Dangoumau, J. [Cardiac toxicity of vincamine: a seven cases report of ventricular arrhythmias by parenteral administration of vincamine (author's transl)]. Therapie
- Fenzl, E., Apecechea, M., Schaltenbr, R., and Fridel, R. Long term study concerning tolerance and efficacy of vinpocetine in elderly patients suffering from a mild to moderate organic psychosyndrome. Senile dementia: early detection 1986;580-585.
- Peruzza, M. and DeJacobis, M. A double-blind placebo controlled evaluation of the efficacy and safety of vinpocetine in the treatment of patients with chronic vascular or degenerative senile cerebral dysfunction. ADV THER 1986;3(4):201-209.
- Manconi, E., Binaghi, F., and Pitzus, F. A double-blind clinical trial of vinpocetine in the treatment of cerebral insufficiency of vascular and degenerative origin. CURR THER RES, CLIN EXP 1986;40(4):702-709.
- Blaha, L., Erzigkeit, H. L., Adamczyk, L. A., Freytag, L. S., and Schaltenbrand, R. Clinical evidence of the effectiveness of vinpocetine in the treatment of organic psychosyndrome. Human Psychopharmacology: Clinical & Experimental 1989;4(2):103-111. DOI
- Shimizu, Y., Saitoh, K., Nakayama, M., Suto, K., Daikohara, R., and Nemoto, T. Agranulocytosis induced by vinpocetine. Medicine On-line 2011;
- Kong L, Song C, Ye L, et al. The Effect of Vinpocetine on Human Cytochrome P450 Isoenzymes by Using a Cocktail Method. Evid Based Complement Alternat Med. 2016;2016:5017135. PubMed
- Vinpocetine in Dietary Supplements. FDA Food/Dietary Supplements/Products & Ingredients. Available at: http://www.fda.gov/Food/DietarySupplements/ProductsIngredients/ucm518478.htm. Accessed 6 September 2016.
- Statement on warning for women of childbearing age about possible safety risks of dietary supplements containing vinpocetine. FDA Food/Dietary Supplements/Products & Ingredients. Available at: https://www.fda.gov/news-events/press-announcements/statement-
- Zhang W, Huang Y, Li Y, et al. Efficacy and safety of vinpocetine as part of treatment for acute cerebral infarction: A randomized, open-label, controlled, multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) trial. Clin Drug Investig 2016; PubMed
- National Toxicology Program. NTP technical report on the prenatal development toxicity studies of vinpocetine (CAS No. 42971-09-5) in Sprague Dawley Rats and New Zealand White Rabbits (Gavage Studies). Research Triangle Park, NC: National Toxicology Progr
- Gutiérrez-Farfán I, Reyes-Legorreta C, Solís-Olguín M, Alatorre-Miguel E, Verduzco-Mendoza A, Durand-Rivera A. Evaluation of vinpocetine as a therapy in patients with sensorineural hearing loss: a phase II, open-label, single-center study. J Pharmacol Sci PubMed
- Hu X, Guo K, Li J, et al. Postoperative ecchymoma of eyelid after botulinum toxin injection for hemifacial spasm: a case report. Front Neurol 2023;14:1171303. PubMed
This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Brands that make products with Vinpocetine
228 brands in our database make a supplement containing Vinpocetine.
Supplement products with Vinpocetine
631 products in our database contain Vinpocetine. Open any to see its full ingredient list and every drug interaction we check.
Vinpocetine: Common Questions
What is Vinpocetine used for, and does it work?
Does Vinpocetine interact with prescription medications?
How are Vinpocetine interactions rated?
Is it safe to take Vinpocetine with my medications?
Where does this Vinpocetine interaction information come from?
What is Vinpocetine used for?
Is Vinpocetine safe to take?
Can I take Vinpocetine if I'm pregnant or trying to get pregnant?
Is Vinpocetine a natural product?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Products that contain Vinpocetine
A rotating sample of real supplements in our database that list Vinpocetine — open any to see its full ingredients and every drug interaction we check.
- PerfectFocus by Nutra Perfect
- Adrenaline Chase by Relentless Pursuit RP
- Animal Rage by Animal
- Cerebro Smart by Viva Vitamins
- Vinpocetine 10 mg by NutraBio
- Vinpo-15 by AOR Advanced Orthomolecular Research Premium
- EnerVital by Source Naturals
- No Bull Lemon Ice by MuscleMeds
- Pump Fuel Insanity Outrageous Orange by PMD
- Remember Me by HoltraCeuticals
Have a question about Vinpocetine?
Our pharmacists answer your medication & supplement questions — free.